Inventaire - your friends and communities are your best library

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis

author

Piercarlo Sarzi-Puttini

Fabiola Atzeni

Mariangela Manfredi

published in: Biologics: Targets and Therapy

date of publication: 2013-03-15

main subject: endothelium, rheumatoid arthritis, rituximab

Cites articles 34

Date

Title

Authors

2011-05-01

Recent advances on the role of cytokines in atherosclerosis

Alain Tedgui, Ziad Mallat, Soraya Taleb
2011-04-01

B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study

Bernard Combe, Xavier Mariette
2010-12-01

Physiological and health implications of a sedentary lifestyle

Travis John Saunders, Genevieve Nissa Healy, Neville Owen
2010-08-06

Cardiac involvement in systemic rheumatic diseases: An update

Marco Matucci-Cerinic, Piercarlo Sarzi-Puttini, Andrea Doria, Roberto Gerli
2010-07-30

The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases

Piercarlo Sarzi-Puttini, Fabiola Atzeni, Maurizio Turiel
2010-07-23

Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?

Piercarlo Sarzi-Puttini
2010-07-05

B cell depletion reduces the development of atherosclerosis in mice

Jean-David Bouaziz, Alain Tedgui, Ziad Mallat, José Vilar, Soraya Taleb, Christoph J Binder
2010-09-03

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis

Tin Kyaw, Abdul Waheed Khan
2010-05-01

Functional impairment of the arterial wall in primary Sjögren's syndrome: combined action of immunologic and inflammatory factors

Yehuda Shoenfeld, Roberto Gerli
2010-02-01

Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis

Joacim Rocklöv, Solbritt Rantapää Dahlqvist, Göran Hallmans
2010-01-28

Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials

Paul Emery
2009-03-11

The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis
2009-03-25

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

Yehuda Shoenfeld, Zoltán Szekanecz, Gyula Szegedi
2008-12-01

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies
2008-09-01

The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis

Frederick Wolfe
2008-08-01

High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study

Cynthia S Crowson, Véronique L. Roger
2008-04-03

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies.

Paul Emery, Tore K. Kvien, Gerd-Rüdiger Burmester
2008-01-15

Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity

Yehuda Shoenfeld, Gyula Szegedi, Gabriella Lakos
2008-12-01

Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy
2006-06-22

Patterns of cardiovascular risk in rheumatoid arthritis

Sebastian Schneeweiss, Jerry Avorn, Daniel H Solomon, Michael E Weinblatt
2006-09-01

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

Paul Emery, Gerd-Rüdiger Burmester, Maxime Dougados, Stanley B Cohen
2005-09-01

The Disease Activity Score and the EULAR response criteria.
2005-08-01

Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort

Nicola J Goodson, Deborah P.M. Symmons, Mark Lunt
2005-03-01

Cardiovascular death in rheumatoid arthritis: a population-based study

Karla V Ballman, Cynthia S Crowson
2004-06-01

Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibody.
2003-03-01

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

Eric Rimm, Meir J Stampfer, JoAnn E. Manson, Elizabeth W Karlson, Daniel H Solomon, Carolyn C Cannuscio, Gary Curhan
2003-06-01

HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis

Ali H. Hajeer, Derek L Mattey
2003-07-01

Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects
2002-04-01

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

Sharon Van Doornum, Geoffrey McColl
2002-08-01

Endothelial function: a barometer for cardiovascular risk?

Joseph Vita, John Keaney
2001-12-01

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
1993-03-01

The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis

Article - wd:Q36702061

Welcome to Inventaire

the library of your friends and communities

learn more